ChabioTech Rises 7.67% Amid Stem Cell Theme Uptrend

On the 4th, the stem cell theme rose 3.16% compared to the previous day, showing strength, while ChabioTech, a related stock drawing attention, surged 7.67% compared to the previous day. ChabioTech is known as a bio company of the Cha Hospital Group.

[Graph] Major stock price changes in the stem cell theme



According to provisional data compiled at 11:06, foreigners are net buying 0.12 ten thousand shares of ChabioTech.

[Table] Net buying/selling volume by foreigners and institutions (unit: ten thousand shares)



According to the analysis by Thinkpool Robo Algorithm RASSI, ChabioTech ranked 2nd out of 23 stocks in the quant financial ranking by exceeding the theme's average scores in growth, stability, and profitability. This can be interpreted as ChabioTech having a relatively high investment attractiveness compared to other stocks in the theme from a financial perspective.

[Table] Top stocks by financial scores within the theme


※ The quant financial score is the result of the robo algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.